Schonfeld Strategic Advisors’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,953,712
| Closed | -$8.21M | – | 2733 |
|
|
2023
Q1 | $8.21M | Buy |
1,953,712
+206,112
| +12% | +$1.07M | 0.08% | 334 |
|
|
2022
Q4 | $10.5M | Buy |
1,747,600
+418,124
| +31% | +$2.28M | 0.09% | 292 |
|
|
2022
Q3 | $7.74M | Buy |
1,329,476
+481,776
| +57% | +$3M | 0.07% | 389 |
|
|
2022
Q2 | $5.06M | Buy |
847,700
+638,100
| +304% | +$3.27M | 0.05% | 467 |
|
|
2022
Q1 | $978K | Buy |
209,600
+38,400
| +22% | +$115K | 0.01% | 1003 |
|
|
2021
Q4 | $424K | Buy |
171,200
+95,200
| +125% | +$233K | ﹤0.01% | 1346 |
|
|
2021
Q3 | $224K | Sell |
76,000
-1,000
| -1% | -$2.72K | ﹤0.01% | 1709 |
|
|
2021
Q2 | $193K | Buy |
77,000
+36,474
| +90% | +$87.5K | ﹤0.01% | 1689 |
|
|
2021
Q1 | $117K | Sell |
40,526
-4,574
| -10% | -$14.9K | ﹤0.01% | 1615 |
|
|
2020
Q4 | $145K | Buy |
+45,100
| New | +$150K | ﹤0.01% | 1398 |
|
